Advancing Innovation in Aquaculture: HEDROS and CENASA Take the Next Step

HEDROS took a significant step toward revolutionizing disease prevention in shrimp farming. Our team met with officials from CENASA, Mexico’s National Animal Health Diagnostic Center, to discuss the validation process for our groundbreaking phage-based solution.

The meeting, held at CENASA’s headquarters in Tecámac, Estado de México, brought together key experts from both organizations. It was an opportunity to present the science behind our product and align expectations on the regulatory process that lies ahead.

At the heart of the conversation was the product’s unique mechanism of action. HEDROS’ Technical Director, Dr. Sergio Martínez, kicked off the session with a visual presentation detailing how our carefully selected phages target Vibrio parahaemolyticus—one of the most devastating bacterial threats to shrimp hatcheries. The discussion that followed was in-depth, covering essential aspects such as dosage protocols, phage stability, and real-world field tests conducted in various environments.

CENASA’s team of experts engaged in a rigorous exchange, raising important questions about the product’s efficacy and genetic composition. Their insights will help shape the final validation process, ensuring our solution meets the highest standards of consistency and reliability.

One key takeaway from the meeting was the importance of moving swiftly. The regulatory process is thorough, and CENASA emphasized the need for precise documentation, including detailed field test reports. We are fully prepared to meet these requirements and are eager to begin the validation phase.

Bringing this innovation to market is not just about meeting regulatory benchmarks—it’s about delivering a powerful, science-backed tool to shrimp farmers facing growing disease challenges. The collaboration with CENASA is a crucial milestone in that journey, and we are excited for what’s ahead.